154 related articles for article (PubMed ID: 9730150)
1. Radiotherapy in the management of Graves' ophthalmopathy.
Sakata K; Hareyama M; Oouchi A; Shidou M; Nagakura H; Morita K; Osanai H; Ohtsuka K; Hinoda Y
Jpn J Clin Oncol; 1998 Jun; 28(6):364-7. PubMed ID: 9730150
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in the radiotherapy of Graves' ophthalmopathy.
Petersen IA; Kriss JP; McDougall IR; Donaldson SS
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):259-64. PubMed ID: 2118493
[TBL] [Abstract][Full Text] [Related]
4. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy.
Prummel MF; Mourits MP; Blank L; Berghout A; Koornneef L; Wiersinga WM
Lancet; 1993 Oct; 342(8877):949-54. PubMed ID: 8105213
[TBL] [Abstract][Full Text] [Related]
5. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743
[TBL] [Abstract][Full Text] [Related]
6. [Retrobulbar irradiation for Graves' ophthalmopathy -- long-term results].
Pitz S; Kahaly G; Rösler HP; Krummenauer F; Wagner B; Stübler M; Pfeiffer N
Klin Monbl Augenheilkd; 2002 Dec; 219(12):876-82. PubMed ID: 12548473
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
[TBL] [Abstract][Full Text] [Related]
8. Supervoltage orbital radiotherapy in 36 cases of Graves' disease.
Lloyd WC; Leone CR
Am J Ophthalmol; 1992 Apr; 113(4):374-80. PubMed ID: 1558110
[TBL] [Abstract][Full Text] [Related]
9. The aftermath of orbital radiotherapy for graves' ophthalmopathy.
Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Buettner H; Robertson DM; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
Ophthalmology; 2002 Nov; 109(11):2100-7. PubMed ID: 12414422
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of radiotherapy for Graves' ophthalmopathy.
Konishi J; Iida Y; Kasagi K; Misaki T; Arai K; Endo K; Amemiya T; Abe M; Torizuka K
Endocrinol Jpn; 1986 Oct; 33(5):637-44. PubMed ID: 3830071
[TBL] [Abstract][Full Text] [Related]
11. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy.
Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
Ophthalmology; 2001 Sep; 108(9):1523-34. PubMed ID: 11535445
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of irradiation for patients with progressive Graves' ophthalmopathy.
Marquez SD; Lum BL; McDougall IR; Katkuri S; Levin PS; MacManus M; Donaldson SS
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):766-74. PubMed ID: 11697323
[TBL] [Abstract][Full Text] [Related]
13. Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease.
Claridge KG; Ghabrial R; Davis G; Tomlinson M; Goodman S; Harrad RA; Potts MJ
Eye (Lond); 1997; 11 ( Pt 5)():717-22. PubMed ID: 9474324
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of orbital irradiation combined with or without systemic high-dose or pulsed corticosteroids for Graves' ophthalmopathy.
Tsujino K; Hirota S; Hagiwara M; Fukada S; Takada Y; Hishikawa Y; Kono M; Abe M
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):857-64. PubMed ID: 11020584
[TBL] [Abstract][Full Text] [Related]
15. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
[TBL] [Abstract][Full Text] [Related]
16. Echographic monitoring of response of extraocular muscles to irradiation in Graves' ophthalmopathy.
Erickson BA; Harris GJ; Lewandowski MF; Murray KJ; Massaro BM
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):651-60. PubMed ID: 7852132
[TBL] [Abstract][Full Text] [Related]
17. Therapy of Graves' ophthalmopathy with intravenous high-dose steroid followed by orbital irradiation.
Koshiyama H; Koh T; Fujiwara K; Hayakawa K; Shimbo S; Misaki T
Thyroid; 1994; 4(4):409-13. PubMed ID: 7711503
[TBL] [Abstract][Full Text] [Related]
18. Extraocular muscle repositioning as the last therapeutic option for a patient with a severe course of Graves' Ophthalmopathy: a case report.
Rau A; Klopfer M; Rommel N; Rau-Fornefeld M; Kolk A
BMC Ophthalmol; 2018 Feb; 18(1):56. PubMed ID: 29482520
[TBL] [Abstract][Full Text] [Related]
19. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy.
Prummel MF; Mourits MP; Berghout A; Krenning EP; van der Gaag R; Koornneef L; Wiersinga WM
N Engl J Med; 1989 Nov; 321(20):1353-9. PubMed ID: 2519530
[TBL] [Abstract][Full Text] [Related]
20. The effect of retrobulbar irradiation on exophthalmos, ductions and soft tissue signs in Graves' ophthalmopathy: a retrospective analysis of 90 cases.
Van Ruyven RL; Van Den Bosch WA; Mulder PG; Eijkenboom WM; Paridaens AD
Eye (Lond); 2000 Oct; 14 Pt 5():761-4. PubMed ID: 11116700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]